Yohann Loriot, Felipe Reyes-Cosmelli, Hernan Javier Cutuli, Giuseppe Fornarini, Terence W. Friedlander, Benjamin Garmezy, Alfonso Gomez De LiaƱo Lista, Nicolas Mainardi, Ignacio Duran, Steffen Rausch, Imanol Martinez Salas, Arlene O. Siefker-Radtke, Wen-Pin Su, Christof Vulsteke, Cong Xu, Leslie R. DeMars, Michael Method, Daniel P. Petrylak. "Interim analysis results from Duravelo-2: Zelenectide pevedotin (zele; BT8009) + pembrolizumab in patients (pts) with previously untreated locally advanced/metastatic urothelial carcinoma (la/mUC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4516